COVID-19 vaccine research challenges and solutions

Accounting for at least 15% of all human pathogens, emerging infectious diseases (EID) pose a significant burden on public health. Vaccination represents one of the most successful prophylactic tools for disease prevention and control, however, the development process is typically lengthy and expensive. While there has been a rapid development of multiple safe and highly effective vaccines in response to the current COVID-19 pandemic, there are still many challenges to overcome. This application note will explore the common challenges of vaccine development and the solutions available to overcome them.